270 related articles for article (PubMed ID: 22095644)
21. Evidence that histidine protonation of receptor-bound anthrax protective antigen is a trigger for pore formation.
Wimalasena DS; Janowiak BE; Lovell S; Miyagi M; Sun J; Zhou H; Hajduch J; Pooput C; Kirk KL; Battaile KP; Bann JG
Biochemistry; 2010 Aug; 49(33):6973-83. PubMed ID: 20672855
[TBL] [Abstract][Full Text] [Related]
22. Receptors of anthrax toxin and cell entry.
van der Goot G; Young JA
Mol Aspects Med; 2009 Dec; 30(6):406-12. PubMed ID: 19732789
[TBL] [Abstract][Full Text] [Related]
23. Interactions of anthrax lethal factor with protective antigen defined by site-directed spin labeling.
Jennings-Antipov LD; Song L; Collier RJ
Proc Natl Acad Sci U S A; 2011 Feb; 108(5):1868-73. PubMed ID: 21262847
[TBL] [Abstract][Full Text] [Related]
24. GRP78(BiP) facilitates the cytosolic delivery of anthrax lethal factor (LF) in vivo and functions as an unfoldase in vitro.
Tamayo AG; Slater L; Taylor-Parker J; Bharti A; Harrison R; Hung DT; Murphy JR
Mol Microbiol; 2011 Sep; 81(5):1390-401. PubMed ID: 21797942
[TBL] [Abstract][Full Text] [Related]
25. Disulfide bonds in the ectodomain of anthrax toxin receptor 2 are required for the receptor-bound protective-antigen pore to function.
Sun J; Collier RJ
PLoS One; 2010 May; 5(5):e10553. PubMed ID: 20479891
[TBL] [Abstract][Full Text] [Related]
26. Solubilization and characterization of the anthrax toxin pore in detergent micelles.
Vernier G; Wang J; Jennings LD; Sun J; Fischer A; Song L; Collier RJ
Protein Sci; 2009 Sep; 18(9):1882-95. PubMed ID: 19609933
[TBL] [Abstract][Full Text] [Related]
27. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
Stiles L; Nelson DJ
J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
[TBL] [Abstract][Full Text] [Related]
28. Crystal structure of a complex between anthrax toxin and its host cell receptor.
Santelli E; Bankston LA; Leppla SH; Liddington RC
Nature; 2004 Aug; 430(7002):905-8. PubMed ID: 15243628
[TBL] [Abstract][Full Text] [Related]
29. Anthrax toxin lethal factor domain 3 is highly mobile and responsive to ligand binding.
Maize KM; Kurbanov EK; De La Mora-Rey T; Geders TW; Hwang DJ; Walters MA; Johnson RL; Amin EA; Finzel BC
Acta Crystallogr D Biol Crystallogr; 2014 Nov; 70(Pt 11):2813-22. PubMed ID: 25372673
[TBL] [Abstract][Full Text] [Related]
30. A novel mechanism for antibody-based anthrax toxin neutralization: inhibition of prepore-to-pore conversion.
Mechaly A; Levy H; Epstein E; Rosenfeld R; Marcus H; Ben-Arie E; Shafferman A; Ordentlich A; Mazor O
J Biol Chem; 2012 Sep; 287(39):32665-73. PubMed ID: 22869370
[TBL] [Abstract][Full Text] [Related]
31. Identification of residues lining the anthrax protective antigen channel.
Benson EL; Huynh PD; Finkelstein A; Collier RJ
Biochemistry; 1998 Mar; 37(11):3941-8. PubMed ID: 9521715
[TBL] [Abstract][Full Text] [Related]
32. Interactions between anthrax toxin receptors and protective antigen.
Scobie HM; Young JA
Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864
[TBL] [Abstract][Full Text] [Related]
33. Effect of 2-fluorohistidine labeling of the anthrax protective antigen on stability, pore formation, and translocation.
Wimalasena DS; Cramer JC; Janowiak BE; Juris SJ; Melnyk RA; Anderson DE; Kirk KL; Collier RJ; Bann JG
Biochemistry; 2007 Dec; 46(51):14928-36. PubMed ID: 18044973
[TBL] [Abstract][Full Text] [Related]
34. Microbiology. Translocation of anthrax toxin: lord of the rings.
von Heijne G
Science; 2005 Jul; 309(5735):709-10. PubMed ID: 16051774
[No Abstract] [Full Text] [Related]
35. Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers.
Feld GK; Thoren KL; Kintzer AF; Sterling HJ; Tang II; Greenberg SG; Williams ER; Krantz BA
Nat Struct Mol Biol; 2010 Nov; 17(11):1383-90. PubMed ID: 21037566
[TBL] [Abstract][Full Text] [Related]
36. Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity.
Panchal RG; Halverson KM; Ribot W; Lane D; Kenny T; Abshire TG; Ezzell JW; Hoover TA; Powell B; Little S; Kasianowicz JJ; Bavari S
J Biol Chem; 2005 Mar; 280(11):10834-9. PubMed ID: 15644338
[TBL] [Abstract][Full Text] [Related]
37. Activity of the Bacillus anthracis 20 kDa protective antigen component.
Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
[TBL] [Abstract][Full Text] [Related]
38. Anthrax toxin translocation complex reveals insight into the lethal factor unfolding and refolding mechanism.
Machen AJ; Fisher MT; Freudenthal BD
Sci Rep; 2021 Jun; 11(1):13038. PubMed ID: 34158520
[TBL] [Abstract][Full Text] [Related]
39. Conformational dynamics of the anthrax lethal factor catalytic center.
Dalkas GA; Chasapis CT; Gkazonis PV; Bentrop D; Spyroulias GA
Biochemistry; 2010 Dec; 49(51):10767-9. PubMed ID: 21121613
[TBL] [Abstract][Full Text] [Related]
40. Exchange characteristics of calcium ions bound to anthrax protective antigen.
Gao-Sheridan S; Zhang S; Collier RJ
Biochem Biophys Res Commun; 2003 Jan; 300(1):61-4. PubMed ID: 12480521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
